Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or

Leonardo Lorente1, Alejandro Jiménez, María M Martín

  • 1Intensive Care Unit, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, La Laguna 38320, Tenerife, Spain. lorentemartin@msn.com

Insights

Continuous infusion of piperacillin/tazobactam (PIP/TAZ) demonstrated higher clinical cure rates for ventilator-associated pneumonia (VAP) compared to intermittent infusion, especially for Gram-negative bacteria with specific minimum inhibitory concentrations.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Piperacillin/tazobactam (PIP/TAZ) is commonly administered via intermittent infusion for bacterial infections.
  • Beta-lactam antibiotics, including PIP/TAZ, exhibit time-dependent activity, suggesting continuous infusion may improve efficacy.
  • Previous studies indicated superior outcomes with continuous infusion of other beta-lactams for ventilator-associated pneumonia (VAP).

Purpose of the Study:

  • To compare the clinical efficacy of continuous versus intermittent infusion of PIP/TAZ in treating VAP.
  • To evaluate the impact of minimum inhibitory concentration (MIC) on treatment outcomes.
  • To assess efficacy in patients without renal failure.

Main Methods:

  • Historical cohort study design.
  • Analysis of clinical cure rates for VAP patients treated with PIP/TAZ via continuous or intermittent infusion.
  • Logistic regression analysis to determine the association between infusion method, MIC, and clinical cure.

Main Results:

  • Continuous infusion showed a significantly higher probability of clinical cure for VAP when the causative microorganism had an MIC of 8 or 16 microg/mL.
  • Odds ratios favored continuous infusion, particularly at higher MICs (OR=10.79 for MIC 8, OR=22.89 for MIC 16).
  • Treatment success rates were substantially higher with continuous infusion (88.9% vs. 40.0% for MIC 8; 87.5% vs. 16.7% for MIC 16).

Conclusions:

  • Continuous infusion of PIP/TAZ may be more effective than intermittent infusion for treating VAP caused by Gram-negative bacteria with MICs of 8-16 microg/mL in non-renal failure patients.
  • Optimizing antibiotic administration strategies, such as continuous infusion, can improve VAP treatment outcomes.
  • Further research may explore the role of pharmacokinetic/pharmacodynamic optimization in VAP management.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...